Myopia, or nearsightedness, is a common eye disorder that affects millions of people worldwide. It occurs when the eye cannot focus on distant objects, causing them to appear blurry. Myopia can be corrected with glasses, contact lenses, or surgery, but these methods do not address the underlying cause of the condition. 

The myopia treatment devices market is expected to witness significant growth in the coming years, as more people seek alternative and innovative solutions for their vision problems. The market attained a value of about USD 7.21 billion in 2023 and is anticipated to rise at a CAGR of 9.10% during the forecast period of 2024-2032 to attain a value of USD 20.67 billion by 2032. The growth of the market is driven by the rising prevalence of myopia, especially among children and young adults, due to factors such as increased screen time, urbanization, and genetic predisposition. The increasing research and developmental activities and technological advancements in the field of ophthalmology also support market growth. 

Market Dynamics 

The global myopia treatment devices market is influenced by various factors that affect the demand and supply of the products. Some of the key drivers and restraints of the market are: 

• Drivers 
• Increasing prevalence of myopia and its complications, such as glaucoma, cataract, and retinal detachment. 
• Growing awareness and preference for minimally invasive and non-surgical treatments, such as orthokeratology, corneal inlays, and implantable collamer lenses. 
• Rising disposable income and healthcare expenditure in emerging economies, such as China, India, and Brazil. 
• Expanding product portfolio and innovation by the key players, such as Essilor, CooperVision, Johnson & Johnson, and Alcon. 
• Restraints 
• High cost and risks associated with some of the myopia treatment devices, such as infection, inflammation, and dry eye syndrome. 
• Lack of awareness and accessibility of some of the advanced devices in the underdeveloped regions. 
• Stringent regulatory policies and approval processes for the medical devices. 

Market Trends 

The global myopia treatment devices market is witnessing some of the emerging trends that shape the future of the industry. Some of the notable trends are: 

• External Factors 
• Increasing adoption of digital devices and online education, especially during the COVID-19 pandemic, which has increased the exposure to blue light and eye strain. 
• Changing lifestyle and environmental factors, such as pollution, lighting, and nutrition, which affect the eye health and vision quality. 
• Growing demand for personalized and customized devices, such as smart contact lenses, that can monitor and adjust the eye parameters. 
• Internal Factors 
• Advancement in the materials and designs of the devices, such as biocompatible, hydrophilic, and multifocal lenses, that offer better comfort and performance. 
• Integration of artificial intelligence and machine learning in the devices, such as smart glasses, that can provide real-time feedback and recommendations. 
• Development of novel and combination therapies, such as pharmacological and gene therapy, that can target the root cause of myopia and prevent its progression. 

Market Segmentation 

The global myopia treatment devices market can be segmented based on the type of device, end-user, and region. The segmentation analysis helps to understand the market size, share, and growth potential of each segment and sub-segment. 

• Type of Device 
• The market can be divided into four types of devices, namely, spectacles, contact lenses, intraocular lenses, and others. 
• Spectacles are the most commonly used and affordable devices for correcting myopia. They are available in various shapes, sizes, and materials, such as plastic, metal, and glass. However, they have some limitations, such as weight, distortion, and inconvenience. 
• Contact lenses are thin and transparent devices that are placed on the surface of the eye. They offer better vision quality, cosmetic appeal, and convenience than spectacles. They can be classified into soft, rigid, and hybrid lenses, depending on the material and flexibility. They can also be categorized into spherical, toric, and multifocal lenses, depending on the shape and function. 
• Intraocular lenses are artificial devices that are implanted inside the eye, either replacing or supplementing the natural lens. They are usually used for severe cases of myopia or when other devices are not suitable or effective. They can be classified into phakic, pseudophakic, and implantable collamer lenses, depending on the position and material of the implant. 
• Others include devices that are not widely used or are still in the experimental stage, such as orthokeratology, corneal inlays, corneal cross-linking, and refractive surgery. They aim to modify the shape or structure of the cornea, which is the front part of the eye that refracts light. 
• End-User 
• The market can be divided into two end-users, namely, hospitals and clinics, and home care. 
• Hospitals and clinics are the major end-users of the market, as they provide diagnosis, prescription, and treatment of myopia. They also have access to the latest and advanced devices and technologies, such as intraocular lenses and refractive surgery. 
• Home care is the emerging end-user of the market, as more people prefer to use devices that are convenient, comfortable, and affordable, such as spectacles and contact lenses. They also have the option to order online and receive delivery at home. 
• Region 
• The market can be divided into five regions, namely, North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. 
• Asia Pacific is the largest and fastest-growing region of the market, owing to the high prevalence of myopia, especially in countries such as China, Japan, and South Korea. The region also has a large population, increasing disposable income, and improving healthcare infrastructure. 
• North America is the second-largest region of the market, due to the high awareness and adoption of myopia treatment devices, especially contact lenses and intraocular lenses. The region also has a well-established and regulated medical device industry, with the presence of key players and innovators. 
• Europe is the third-largest region of the market, because of the increasing demand for myopia treatment devices, especially spectacles and contact lenses. The region also has a high-quality and accessible healthcare system, with the support of government and private funding. 
• Latin America and Middle East and Africa are the emerging regions of the market, as they have a growing population, rising urbanization, and developing healthcare sector. However, they face some challenges, such as low awareness, affordability, and availability of myopia treatment devices. 

Market Growth 

The global myopia treatment devices market is projected to grow at a robust rate in the next decade, as the demand for the devices is expected to increase with the rising prevalence of myopia and its complications. The market is also expected to benefit from the technological innovations and product launches by the key players, who are investing heavily in the research and development of the devices. The market is also likely to witness new opportunities and challenges, as external and internal factors influence the market dynamics and trends. 

Recent Developments 

The global myopia treatment devices market is witnessing some of the recent developments that reflect the current and future scenario of the industry. Some of the notable developments are: 

• In April 2021, Johnson & Johnson Vision announced the launch of Acuvue Abiliti, a new brand of contact lenses and eye care solutions for myopia management. The brand aims to provide a comprehensive and personalized approach to slow down the progression of myopia in children and adolescents. 
• In March 2021, Essilor International announced the acquisition of SightGlass Vision, a US-based company that develops spectacle lenses for myopia control. The acquisition is expected to strengthen Essilor's portfolio and position in the myopia treatment devices market. 
• In February 2021, CooperVision announced the expansion of its MiSight 1 day contact lens, the first and only FDA-approved contact lens for myopia control, to more countries in Europe, Middle East, and Africa. The contact lens is designed to slow down the elongation of the eye, which is the main cause of myopia. 
• In January 2021, Alcon announced the launch of AcrySof IQ Vivity, a presbyopia-correcting intraocular lens that can also treat myopia and astigmatism. The lens is based on a proprietary technology that creates a continuous and extended range of vision, without compromising on contrast or quality. 

Key Players 

The global myopia treatment devices market is highly competitive and fragmented, with the presence of several local and global players. Some of the key players in the market are: 

• Essilor International SA 
• CooperVision Inc. 
• Johnson & Johnson Vision Care Inc. 
• Alcon Inc. 
• Bausch Health Companies Inc. 
• Carl Zeiss AG 
• Hoya Corporation 
• Nidek Co. Ltd. 
• Staar Surgical Company 
• Topcon Corporation 

These players are adopting various strategies, such as mergers and acquisitions, partnerships and collaborations, product launches and innovations, and research and development, to gain a competitive edge and expand their market share. 

FAQs 

Some of the frequently asked questions about the global myopia treatment devices market are: 

• What is myopia and how is it diagnosed? 

Myopia, or nearsightedness, is a common eye disorder that affects the ability to see distant objects clearly. It is diagnosed by an eye examination, which measures the refractive error and the visual acuity of the eye. 

• What are the types and causes of myopia? 

There are two types of myopia, namely, axial and refractive. Axial myopia occurs when the eye is too long, causing the light to focus in front of the retina. Refractive myopia occurs when the cornea or the lens is too curved, causing the light to bend too much. The causes of myopia are not fully understood, but they are believed to be a combination of genetic and environmental factors, such as screen time, urbanization, and education. 

• What are the symptoms and complications of myopia? 

The main symptom of myopia is blurry vision, especially for distant objects. Other symptoms may include eye strain, headache, squinting, and fatigue. The complications of myopia may include glaucoma, cataract, retinal detachment, and macular degeneration, which can lead to vision loss. 

• What are the treatment options for myopia? 

The treatment options for myopia depend on the severity and the preference of the patient. The most common options are spectacles, contact lenses, and intraocular lenses, which correct the refractive error and improve the vision quality. Other options include orthokeratology, corneal inlays, corneal cross-linking, and refractive surgery, which modify the shape or structure of the cornea and reduce the dependence on the corrective devices. 

• What are the advantages and disadvantages of the myopia treatment devices? 

The advantages and disadvantages of the myopia treatment devices vary depending on the type, cost, effectiveness, and safety of the device. Some of the general advantages are better vision quality, cosmetic appeal, and convenience. Some of the general disadvantages are high cost, risks of infection, inflammation, and dry eye syndrome, and need for regular maintenance and replacement. 

Media Contact:

Company Name: Claight Corporation
Contact Person: Joe Goldberg, Business Consultant
Email: sales@expertmarketresearch.com
Toll-Free Number: US +1-415-325-5166 | UK +44-702-402-5790
Address: 30 North Gould Street, Sheridan, WY 82801, USA